{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:21:01Z","timestamp":1794860461710,"version":"4.9.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder caused by mutations in the <jats:italic>TSC1<\/jats:italic> and <jats:italic>TSC2<\/jats:italic> genes and autosomal dominantly inherited. These mutations cause hyperactivation of the mammalian Target of Rapamycin (mTOR) pathway, leading to the development of nonmalignant masses involving various organ systems. Patients with TSC also experience neuropsychiatric symptoms collectively termed Tuberous Sclerosis Complex Associated Neuropsychiatric Disorder (TAND). Due to research advancements in TSC, patients now live well beyond the age of 50. Many experience objective impairment of memory and executive function, supported by formal neuropsychological testing, beginning in their late 40s. Biomarker analysis has described elevated levels of phosphorylated tau-181 in the cerebrospinal fluid of patients with TAND. Tau-PET imaging has also shown focal accumulation of the radiotracer flortaucipir (AV1451), suggesting that TSC may be a neurodegenerative disorder arising from accumulation of phosphorylated tau. However, the flortaucipir tracer has been reported to have significant off-target binding, preventing definitive conclusions from being drawn about the molecular etiology of neurodegeneration in TSC. Therefore, we initiated the Colocalization of AV1451 and Phosphorylated Tau in Adult brain tissue (CAPA) study. This study aimed to determine if flortaucipir is bound to phosphorylated tau in brains of patients with TSC and further sought to determine the specific tau isoform seen in TSC. Our results show that flortaucipir labels the 3R\/4R isoform of phosphorylated tau, commonly seen in Alzheimer\u2019s disease. However, amyloid staining was negative in brains of adult patients with TSC. Therefore, we conclude that TAND symptoms are due to the accumulation of the phosphorylated tau isoform seen in Alzheimer\u2019s disease. This study suggests that hyperactivation of the mammalian Target of Rapamycin pathway may play a role in the amyloid-independent development of 3R\/4R tau aggregation. Our findings could lead to a new era of anti-tau therapies used to treat both disorders.\n<\/jats:p>","DOI":"10.1186\/s40478-022-01330-x","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T13:05:54Z","timestamp":1646312754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tuberous sclerosis complex is a novel, amyloid-independent tauopathy associated with elevated phosphorylated 3R\/4R tau aggregation"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3096-1788","authenticated-orcid":false,"given":"Andy J.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay B.","family":"Lusk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ervin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsiu J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"1330_CR1","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.2967\/jnumed.118.224113","volume":"60","author":"SL Baker","year":"2019","unstructured":"Baker SL, Harrison TM, Maass A, La JR, Jagust WJ (2019) Effect of off-target binding on 18F-flortaucipir variability in healthy controls across the life span. J Nucl Med 60:1444\u20131451. https:\/\/doi.org\/10.2967\/jnumed.118.224113","journal-title":"J Nucl Med"},{"key":"1330_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jalz.2018.07.215","volume":"15","author":"WR Bell","year":"2019","unstructured":"Bell WR, An Y, Kageyama Y, English C, Rudow GL, Pletnikova O, Thambisetty M, O\u2019Brien R, Moghekar AR, Albert MS, Rabins PV, Resnick SM, Troncoso JC (2019) Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer\u2019s disease. Alzheimers Dement J Alzheimers Assoc 15:8\u201316. https:\/\/doi.org\/10.1016\/j.jalz.2018.07.215","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"1330_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2147\/NDT.S75717","volume":"11","author":"Z Cai","year":"2015","unstructured":"Cai Z, Chen G, He W, Xiao M, Yan L-J (2015) Activation of mTOR: a culprit of Alzheimer\u2019s disease? Neuropsychiatr Dis Treat 11:1015\u20131030. https:\/\/doi.org\/10.2147\/NDT.S75717","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1330_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","volume":"7","author":"K Iqubal","year":"2010","unstructured":"Iqubal K, Liu F, Gong CXG-II (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimers Res 7:656\u2013664. https:\/\/doi.org\/10.2174\/156720510793611592","journal-title":"Curr Alzheimers Res"},{"key":"1330_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.4284","author":"AJ Liu","year":"2019","unstructured":"Liu AJ, Staffaroni AM, Rojas-Martinez JC, Olney NT, Alquezar-Burillo C, Ljubenkov PA, La Joie R, Fong JC, Taylor J, Karydas A, Ramos EM, Coppola G, Boxer AL, Rabinovici GD, Miller BL, Kao AW (2019) Association of cognitive and behavioral features between adults with tuberous sclerosis and frontotemporal dementia. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4284","journal-title":"JAMA Neurol"},{"key":"1330_CR6","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.15252\/emmm.201707809","volume":"9","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Sch\u00f6ll M, Strandberg O, Smith R, Palmqvist S, Insel PS, H\u00e4gerstr\u00f6m D, Ohlsson T, Zetterberg H, J\u00f6gi J, Blennow K, Hansson O (2017) 18 F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer\u2019s disease. EMBO Mol Med 9:1212\u20131223. https:\/\/doi.org\/10.15252\/emmm.201707809","journal-title":"EMBO Mol Med"},{"key":"1330_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3389\/fnins.2018.01017","volume":"12","author":"Z Mueed","year":"2019","unstructured":"Mueed Z, Tandon P, Maurya SK, Deval R, Kamal MA, Poddar NK (2019) Tau and mTOR: the hotspots for multifarious diseases in Alzheimer\u2019s development. Front Neurosci 12:1017. https:\/\/doi.org\/10.3389\/fnins.2018.01017","journal-title":"Front Neurosci"},{"key":"1330_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup H, Krueger DA, Roberds S, Smith K, Sampson J, Korf B, Kwiatkowski DJ, Mowat D, Nellist M, Povey S, de Vries P, Byars A, Dunn D, Ess K, Hook D, Jansen A, King B, Sahin M, Whittemore V, Thiele E, Bebin EM, Chugani HT, Crino P, Curatolo P, Holmes G, Nabbout R, O\u2019Callaghan F, Wheless J, Wu J, Darling TN, Cowen EW, Gosnell E, Hebert A, Mlynarczyk G, Soltani K, Teng J, Wataya-Kaneda M, Witman PM, Kingswood C, Bissler J, Budde K, Hulbert J, Guay-Woodford L, Sauter M, Zonneberg B, J\u00f3\u017awiak S, Bartels U, Berhouma M, Franz DN, Koenig MK, Roach ES, Roth J, Wang H, Weiner H, McCormack FX, Almoosa K, Brody A, Burger C, Cottin V, Finlay G, Glass J, Henske EP, Johnson S, Kotloff R, Lynch D, Moss J, Rhu J, Da Silva AT, Young LR, Knilans T, Hinton R, Prakash A, Romp R, Singh AD, Debroy A, Chen PL, Sparagana S, Frost MD (2013) Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol 49:243\u2013254. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.08.001","journal-title":"Pediatr Neurol"},{"key":"1330_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00401-017-1764-0","volume":"134","author":"NT Olney","year":"2017","unstructured":"Olney NT, Alquezar C, Ramos EM, Nana AL, Fong JC, Karydas AM, Taylor JB, Stephens ML, Argouarch AR, Van Berlo VA, Dokuru DR, Sherr EH, Jicha GA, Dillon WP, Desikan RS, De May M, Seeley WW, Coppola G, Miller BL, Kao AW (2017) Linking tuberous sclerosis complex, excessive mTOR signaling, and age-related neurodegeneration: a new association between TSC1 mutation and frontotemporal dementia. Acta Neuropathol (Berl) 134:813\u2013816. https:\/\/doi.org\/10.1007\/s00401-017-1764-0","journal-title":"Acta Neuropathol (Berl)"},{"key":"1330_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.braindev.2014.08.010","volume":"37","author":"HB Sarnat","year":"2015","unstructured":"Sarnat HB, Flores-Sarnat L (2015) Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma. Brain Dev 37:553\u2013562. https:\/\/doi.org\/10.1016\/j.braindev.2014.08.010","journal-title":"Brain Dev"},{"key":"1330_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pediatrneurol.2021.06.009","volume":"123","author":"C Sidira","year":"2021","unstructured":"Sidira C, Vargiami E, Anastasiou A, Talimtzi P, Kyriazi M, Dragoumi P, Spanou M, Ntinopoulos A, Dalpa E, Evangeliou A, Zafeiriou DI (2021) The complex interplay of cortex, cerebellum, and age in a cohort of pediatric patients with tuberous sclerosis complex. Pediatr Neurol 123:43\u201349. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.06.009","journal-title":"Pediatr Neurol"},{"key":"1330_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00603","author":"PJ de Vries","year":"2020","unstructured":"de Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, D\u2019Amato L, Beaure d\u2019 Aug\u00e8res G, Ferreira JC, Feucht M, Fladrowski C, Hertzberg C, Jozwiak S, Lawson JA, Macaya A, Marques R, Nabbout R, O\u2019Callaghan F, Qin J, Sander V, Sauter M, Shah S, Takahashi Y, Touraine R, Youroukos S, Zonnenberg B, Kingswood JC, Jansen AC, Investigators T, Shinohara N, Horie S, Kubota M, Tohyama J, Imai K, Kaneda M, Kaneko H, Uchida Y, Kirino T, Endo S, Inoue Y, Uruno K, Serdaroglu A, Yapici Z, Anlar B, Altunbasak S, Lvova O, Belyaev OV, Agranovich O, Levitina EV, Maksimova YV, Karas A, Jiang Y, Zou L, Xu K, Zhang Y, Luan G, Zhang Y, Wang Y, Jin M, Ye D, Liao W, Zhou L, Liu J, Liao J, Yan B, Deng Y, Jiang L, Liu Z, Huang S, Li H, Kim K, Chen P-L, Lee H-F, Tsai J-D, Chi C-S, Huang C-C, Riney K, Yates D, Kwan P, Likasitwattanakul S, Nabangchang C, Chomtho LTK, Katanyuwong K, Sriudomkajorn S, Wilmshurst J, Segel R, Gilboa T, Tzadok M, Fattal-Valevski A, Papathanasopoulos P, Papavasiliou AS, Giannakodimos S, Gatzonis S, Pavlou E, Tzoufi M, Vergeer AMH, Dhooghe M, Verhelst H, Roelens F, Nassogne MC, Defresne P, Waele LD, Leroy P, Demonceau N, Legros B, Bogaert PV, Ceulemans B, Dom L, Castelnau P, Martin ADS, Riquet A, Milh M, Cances C, Pedespan J-M, Ville D, Roubertie A, Auvin S, Berquin P, Richelme C, Allaire C, Gueden S, Tich SNT, Godet B, Rojas MLRF, Planas JC, Bermejo AM, Dura PS, Aparicio SR, Gonzalez MJM, Pison JL, Barca MOB, Laso EL, Luengo OA, Rodriguez FJA, Dieguez IM, Salas AC, Carrera IM, Salcedo EM, Petri MEY, Candela RC, da Carrilho IC, Vieira JP, da Monteiro JPSO, de Leao MJSOF, Luis CSMR, Mendonca CP, Endziniene M, Strautmanis J, Talvik I, Canevini MP, Gambardella A, Pruna D, Buono S, Fontana E, Bernardina BD, Burloiu C, Cosma ISB, Vintan MA, Popescu L, Zitterbart K, Payerova J, Bratsky L, Zilinska Z, Gruber-Sedlmayr U, Baumann M, Haberlandt E, Rostasy K, Pataraia E, Elmslie F, Johnston CA, Crawford P, Uldall P, Uvebrant P, Rask O, Bjoernvold M, Brodtkorb E, Sloerdahl A, Solhoff R, Jaatun MSG, Mandera M, Radzikowska EJ, Wysocki M, Fischereder M, Kurlemann G, Wilken B, Wiemer-Kruel A, Budde K, Marquard K, Knuf M, Hahn A, Hartmann H, Merkenschlager A, Trollmann R (2020) Tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): new findings on age, sex, and genotype in relation to intellectual phenotype. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.00603","journal-title":"Front Neurol"},{"key":"1330_CR13","doi-asserted-by":"publisher","unstructured":"de Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, D\u2019Amato L, Beure d\u2019Aug\u00e8res G, Ferreira JC, Feucht M, Fladrowski C, Hertzberg C, Jozwiak S, Lawson JA, Macaya A, Marques R, Nabbout R, O\u2019Callaghan F, Qin J, Sander V, Sauter M, Shah S, Takahashi Y, Touraine R, Youroukos S, Zonnenberg B, Kingswood JC, Jansen AC, TOSCA Consortium and TOSCA Investigators (2020) Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project. J Neurodev Disord 12:24. https:\/\/doi.org\/10.1186\/s11689-020-09327-0","DOI":"10.1186\/s11689-020-09327-0"},{"key":"1330_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","volume":"52","author":"PJ De Vries","year":"2015","unstructured":"De Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, Hook D, King BH, Sahin M, Jansen A (2015) Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist. Pediatr Neurol 52:25\u201335. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2014.10.004","journal-title":"Pediatr Neurol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01330-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T13:24:58Z","timestamp":1646313898000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01330-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1330"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01330-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Duke University IRB approved protocol (protocol ID: Pro00105057) was completed prior to obtaining brain tissue from the NIH biobank.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}